论文信息 - The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis - 字舞流文

The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis

D. Abraham | C. Denton | I. Konstantinova | J. Junien | V. Ong | X. Shiwen | O. Lacombe | P. Broqua | R. Hoyles | E. Derrett-Smith | K. E. Clark | Kristina E N Clark